
what is triamcinolone acetonide cream 0.1 used to treat
Aug 08, 2016 02:26 PM IST IST | Source: PTI
Glenmark Pharmaceuticals has accustomed final nod from the US bloom regulator for all-encompassing Triamcinolone acetonide chrism acclimated for abbreviation itching, bloom and abscess on skin.
Company's US accessory "Glenmark Pharmaceuticals Inc has been accepted final approval by the United States Food and Biologic Administration (USFDA) for Triamcinolone acetonide chrism USP, 0.1 percent," Glenmark said in a BSE filing.
The artefact is all-encompassing adaptation of Delcor Asset Corporation's Kenalog chrism in the aforementioned strength, it added.
According to IMS Bloom sales abstracts for the 12-month aeon concluded June 2016, the Kenalog cream, 0.1 per cent bazaar (includes cast and all accessible ameliorative equivalents) accomplished anniversary sales of about USD 43.6 million, Glenmark said.
Company's accepted portfolio consists of 108 articles authorised for administration in the US exchange and 61 abbreviated new biologic applications (ANDA's) awaiting approval with the USFDA, it added.
Shares of Glenmark Pharmaceuticals were trading 1.32 percent up at Rs 854.00 on BSE.
["279.36"]

["279.36"]

["486.94"]

["488.88"]
["582"]

["384.12"]

["1862.4"]

["388"]
["279.36"]

["271.6"]